Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can peer mentors help stop HIV transmission from mother to child?

NCT ID NCT06999928

Disease control Sponsor: Indiana University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 11, 2026 · Last updated Aug 12, 2026 · Updated 1 time

Summary

This study tests an enhanced Mentor Mother strategy, where trained peer counselors provide tailored support to pregnant and postpartum women living with HIV. The goal is to see if this approach can be successfully implemented and improve health outcomes, such as keeping mothers in care, achieving viral suppression, and preventing HIV transmission to infants. The study will compare outcomes before and after the strategy is introduced at one clinic in Kenya, and also compare with other clinics offering standard care.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Enhanced Mentor Mother strategy, a behavioral intervention involving trained peer counselors who provide tailored support to pregnant and postpartum women living with HIV.
What this could lead to
If successful, this approach could improve HIV care for mothers and reduce the chance of passing HIV to their babies in resource-limited settings.
What could go wrong
This is a pilot study, so results may not be definitive. The strategy's success depends on how well it can be implemented in real-world clinics, and individual outcomes may vary.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 200 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jul 2025

Expected to finish

Oct 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Female participants only

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Pregnant and postpartum women living with HIV (and their infants born during the study) * ≥18 years of age * Enrolled in PMTCT services at BFSDH * Able to understand and provide informed consent in English or Kiswahili Exclusion Criteria: * Women who are not pregnant or postpartum * \<18 years of age * Not enrolled in PMTCT services at BFSDH * Unable to understand and provide informed consent in English or Kiswahili * Cognitive impairment that would interfere with ability to participate in the study

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Adherence, treatment are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

AIDS Financial Stress HIV infectious disease Patient Acceptance of Health Care Stereotyping Treatment Adherence and Compliance Viremia congenital human immunodeficiency virus prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Adherence, treatment Health care acceptability Health care utilization HIV Mothers Peer group Socioeconomic adversity Stigmatization Transmission vertical Viremia

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Burnt Forest Sub-District Hospital

    RECRUITING

    Burnt Forest, Uasin Gishu County, 30100, Kenya

More trials for these conditions

Other studies related to the condition(s) this trial covers.